Bayesian Health vs Glass Health

Glass publishes $0, $20, $90 and $200 per month. Bayesian Health lists no price, and Medicare's new technology add-on payment of up to $61.84 per eligible inpatient case, effective October 1, 2026, goes to the hospital rather than to the vendor.

A hospital CMIO weighing the two is choosing between a monitor and a physician assistant. The FDA cleared Bayesian's sepsis flagging device as K250680 on April 30, 2026. It reads EHR data continuously and puts a Sepsis Risk High flag in the chart for adults, and the clearance says it is not the sole basis for diagnosis. The 18% lower in-hospital mortality when alerts were acted on is the vendor's figure from a 2022 observational Nature Medicine study. Glass claims no FDA status. It sells a scribe, differentials and note drafting, with Epic and athenahealth workflows only on Max at $200 per month. A CMIO who needs a cleared tool for sepsis surveillance rules Glass out. A CMIO whose problem is documentation time gets no scribe from Bayesian.